Tuesday, August 14, 2012

Research Provides New Clues For Schizophrenia Drug Development

 Around 1% of the world's population suffers from schizophrenia. However, around 30% of patients do not respond to current drugs for treating schizophrenia. In a study published online in Nature Neuroscience, researchers of the Mount Sinai School of Medicine may now have discovered the reasons for this. The discovery opens the door for a new class of drugs that can help in treating this devastating mental illness.

Research Provides New Clues For Schizophrenia Drug Development

No comments: